Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa

BACKGROUND: Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)–related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. METHODS: We projected intensive care unit (ICU) needs and capacity fr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Jo, Youngji, Jamieson, Lise, Edoka, Ijeoma, Long, Lawrence, Silal, Sheetal, Pulliam, Juliet R C, Moultrie, Harry, Sanne, Ian, Meyer-Rath, Gesine, Nichols, Brooke E
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928624/
https://ncbi.nlm.nih.gov/pubmed/33732750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados